A Study of the effects of an investigational omega 3 fatty acid treatment on the reduction of heart problems (STRENGTH Study)

What we are studying

High triglyceride levels can add to the bad effect of known risk factors for heart disease and stroke such as high cholesterol, diabetes and high blood pressure. Statins are a group of drugs used to lower cholesterol and have been shown to be effective in reducing heart attack and stroke. However, a significant number of people who receive statins continue to be at high risk because their triglyceride levels remain high. The STRENGTH study will examine whether taking the investigational treatment Epanova® (an omega-3 fatty acid capsule which can lower triglycerides) together with a statin reduces the risk of heart attack and stroke when compared to taking the statin with corn oil (also in capsule form).

Who is Eligible

  • Genders:
    • Men
    • Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Diagnosed with heart disease (includes having had a heart attack or heart procedure)
  • Peripheral vascular disease
  • Carotid artery disease (includes history of stroke)
  • Or diabetes (type 1 or 2).

What is involved

  • 14 visits to CRU over 3-5 yr study period
  • 9 telephone follow ups over 3-5 yr study period
  • Routine blood labs
  • Physical exams
  • Blood pressure checks
  • And 1 EKG


Subjects will receive a $50 gift card at each clinic visit.

Contact Information

Study Coordinator
Vickie Wayne
Principal Investigator
Dr. David Herrington, Cardiologist

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.